Literature DB >> 487156

Symmetric bilateral changes in dopamine release from the caudate nuclei of the cat induced by unilateral nigral application of glycine and GABA-related compounds.

V Leviel, A Chéramy, A Nieoullon, J Glowinski.   

Abstract

The release of [3H]DA synthesized from [3H]tyrosine was estimated in the two caudate nuclei (CN) during the unilateral nigral application of glycine and GABA-related compounds in 'encéphale isolé' cats using push-pull cannulae. Glycine (10(-5) M) reduced the release of [3H]DA in both CN and these effects were antagonized by strychnine (10(-5) M). A decrease in [3H]DA release was also seen in both CN during the unilateral nigral application of diazepam (10(-5) M). In contrast, muscimol (10(-6) M) and GABA (10(-5) M) stimulated [3H]DA release on both sides. The effect of GABA was blocked by picrotoxin (10(-5) M). Picrotoxin alone stimulated the release of [3H]DA in the ipsilateral CN and was without effect in the contralateral side. Bicuculline (10(-5) M) stimulated [3H]DA release only in the contralateral CN. A symmetric increase in [3H]DA release in both CN was also observed during the unilateral nigral application of potassium (30 mM). A model involving a facilitatory polysynaptic pathway originating from the substantia nigra (SN) and acting presynaptically on ther terminals of the contralateral DA neurons is proposed to explain the changes in [3H]DA release induced in the contralateral CN in these various situations. The results are discussed taking into account previous data on the reciprocal control of the two dopaminergic pathways induced by the unilateral nigral application of dopaminergic drugs.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 487156     DOI: 10.1016/0006-8993(79)91005-9

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  10 in total

1.  Foetal nigral cell suspension grafts influence dopamine release in the non-grafted side in the 6-hydroxydopamine rat model of Parkinson's disease: in vivo voltammetric data.

Authors:  C D Earl; T Reum; J X Xie; J Sautter; A Kupsch; W H Oertel; R Morgenstern
Journal:  Exp Brain Res       Date:  1996-04       Impact factor: 1.972

2.  Motor effects following application of putative excitatory amino acid antagonists to the region of the mesencephalic dopamine cell bodies in the rat.

Authors:  D Dawbarn; C J Pycock
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1981-12       Impact factor: 3.000

3.  The effects of muscimol and picrotoxin injections into the cat substantia nigra.

Authors:  S Wolfarth; W Kolasiewicz; K H Sontag
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1981-08       Impact factor: 3.000

4.  Basal ganglia outflow pathways and circling behaviour in the rat.

Authors:  P N Leigh; C Reavill; P Jenner; C D Marsden
Journal:  J Neural Transm       Date:  1983       Impact factor: 3.575

5.  Glycine-evoked release of [3H]acetylcholine from rat striatal slices is independent of the NMDA receptor.

Authors:  C A Taylor; C Tsai; J Lehmann
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-05       Impact factor: 3.000

6.  A biochemical basis for psychotic symptoms in patients with brain dysfunction.

Authors:  R Waziri; J Mott
Journal:  Eur Arch Psychiatry Neurol Sci       Date:  1987

7.  The release of endogenous GABA and glutamate from the cerebral cortex in the rat.

Authors:  F Moroni; R Corradetti; F Casamenti; G Moneti; G Pepeu
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1981-06       Impact factor: 3.000

8.  GABA in the thalamic motor nuclei modulates dopamine release from the two dopaminergic nigrostriatal pathways in the cat.

Authors:  M F Chesselet; A Cheramy; R Romo; M Desban; J Glowinski
Journal:  Exp Brain Res       Date:  1983       Impact factor: 1.972

9.  Antagonism of phencyclidine-induced hyperactivity by glycine in mice.

Authors:  E Toth; A Lajtha
Journal:  Neurochem Res       Date:  1986-03       Impact factor: 3.996

10.  In vivo evidence for a concordant response of terminal and dendritic dopamine release during intranigral infusion of drugs.

Authors:  B H Westerink; M Santiago; J B De Vries
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-12       Impact factor: 3.000

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.